Collectively, our findings reveal a link between miR-193b-3p deficiency and ERBB4 protein hyperactivation in psoriasis, which leads to abnormal proliferation and aberrant inflammation of keratinocytes, highlighting the potential use of miR-193b-3p as a novel therapeutic intervention for psoriasis. Here, ERBB4 is linked to psoriasis.